Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD‐L1 expression in cancer patients-Reference-Cited by-同舟云学术

Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD‐L1 expression in cancer patients

Published:2020-06 Issue:11 Volume:146 Page:3087-3097
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Nikanjam Mina¹^ORCID,Arguello David²,Gatalica Zoran²,Swensen Jeff²,Barkauskas Donald A.³,Kurzrock Razelle¹^ORCID

Affiliation:

1. Center for Personalized Cancer Therapy, Division of Hematology and OncologyUniversity of California San Diego Moores Cancer Center San Diego CA

2. Caris Life Sciences, Inc Phoenix AZ

3. Department of Preventive Medicine, Biostatistics Division, Keck School of MedicineUniversity of Southern California Los Angeles CA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32661

Reference50 articles.

1. Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities

2. Immuno-oncology combinations: raising the tail of the survival curve

3. Dosing immunotherapy combinations: Analysis of 3,526 patients for toxicity and response patterns

4. Combination immunotherapy: a road map

5. Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nomogram of myelosuppression and survival prognosis in patients with brain metastases from non-small cell lung adenocarcinoma by intrathecal injection of pemetrexed via the Ommaya Reservoir;2023-11-20

2. Targeting BRCA‐mutant biliary tract cancer: Current evidence and future perspectives;Journal of Digestive Diseases;2023-02

3. A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours;Scientific Reports;2022-11-28

4. PIK3CA somatic mutations as potential biomarker for immunotherapy in elder or TP53 mutated gastric cancer patients;Clinical Genetics;2022-11-24

5. Accuracy of next-generation sequencing for molecular profiling of small specimen of lung cancer: a prospective pilot study of side-by-side comparison;Diagnostic Pathology;2022-10-12